Background: The ageing of the population may be anticipated to increase demand on hospital resources. We have investigated the relationship between hospital episode costs and age profile in a single centre. Methods: All Emergency Medical admissions (33 732 episodes) to an Irish hospital over a 6-year period, categorized into three age groups, were evaluated against total hospital episode costs. Univariate and adjusted incidence rate ratios (IRRs) were calculated using zero truncated Poisson regression. Results: The total hospital episode cost increased with age (P < 0.001). The multi-variable Poisson regression model demonstrated that the most important drivers of overall costs were Acute Illness Severity-IRR 1.36 (95% CI: 1.30, 1.41), Sepsis Status À1.46 (95% CI: 1.42, 1.51) and Chronic Disabling Disease Score -1.25 (95% CI: 1.22, 1.27) and the Age Group as exemplified for those >85 years IRR 1.23 (95% CI: 1.15, 1.32). Conclusion: Total hospital episode costs are a product of clinical complexity with contributions from the Acute Illness Severity, Co-Morbidity, Chronic Disabling Disease Score and Sepsis Status. However age is also an important contributor and an increasing patient age profile will have a predictable impact on total hospital episode costs.
Introduction
Acute care for emergency medical admissions is increasingly complex following the demographic trends imposed by an ageing population; in which there is a shift from acute to chronic 'disabling' conditions. Where life expectancy has increased by 4.0 and 2.6 years for males and females respectively from 1970 to 2010, the time spent with a chronic 'disabling' condition increased by 9.2 and 9.4 years for males and females respectively in the same time period. 1 Consequently, the complexity and costs of acute healthcare delivery can be anticipated to increase. Further demographic shifts are expected to lead to greater scrutiny of spiraling health budgets and call into question the financial sustainability of current funding mechanisms. The OECD have predicted that the average health expenditure to GDP ratio will rise from 5.5% to 12% by 2060 in a 'worst case' costpressure scenario. 2 Naturally, this leads to the study of factors that may be modulated with a view to maximizing the efficiency and minimizing the waste of our health services.
Although age, considered in isolation, might be expected to be a predictor of hospital length of stay and costs, the extent to which disease complexity; as reflected by Acute Illness Severity, 3, 4 Charlson Co-Morbidity Index, 5 Chronic Disabling Disease 6 and Sepsis Status 7 ; drive these is unclear. In this article, we set out to identify the predictive factors that largely determine the cost of acute care provision.
Methods

Background
St James's Hospital (SJH) serves as a secondary care centre for emergency admissions for its catchment area of 270 000 adults. Emergency medical patients are admitted from the Emergency Department (ED) to an Acute Medical Admission Unit (AMAU), under the care of the 'on-call' physician-the operation and outcome of which have been described elsewhere.
3,8
Data collection
For audit purposes, we employed an anonymous patient database assembling core information about each clinical episode from elements contained on the patient administration system, the national hospital in-patient enquiry (HIPE) scheme, the patient electronic record, the emergency room and laboratory systems. Data held on the database includes the unique hospital number, patient demographics, principal and secondary diagnoses, principal and secondary procedures, admission and discharge dates. Additional information cross-linked and automatically uploaded to the database includes physiological and laboratory parameters. Data collected from the years 2008 to 2013 was analysed. We considered each patient once only for the purposes of this assessment: if there was more than one admission, we used the last admission. Approximately 9.9% of our patients stay >30 days with a median LOS of 54.8 days (IQR 38.8, 97.2). 9 Approximately 5% of patients remain after 30 days are awaiting institutional long-term care placement and not in hospital for medical reasons having completed the episode. Therefore a truncated end-point (death or episode completed by the 30-day endpoint) was chosen for analysis, to avoid the additional confounding of non-medical reasons for continuing as an inpatient.
Statistical methods
Descriptive statistics were calculated for background demographic data, including means/SD, medians/inter-quartile ranges (IQR), or percentages. Comparisons between categorical variables and mortality were made using chi-square tests. For the cost data, we employed a truncated Poisson regression model, including predictive categorical variables in the model as a series of indicator variables. The data were regressed against total costs using the truncated Poisson model, using which; we can interpret the coefficients in terms of incidence rate ratios (IRR). Adjusted odds ratios (OR) and 95% CI or IRRs were calculated for those predictors that significantly entered the model (P < 0.10). We modeled using variables that had been univariate predictors of total hospital cost. These included Acute Illness Severity, 3, 4 Charlson Co-Morbidity Index, 5 Chronic
Disabling Disease Score 6 and Sepsis status 7 ; the details of which are outlined below.
Risk predictors
Derangement of admission biochemical parameters may be utilized to predict clinical outcome. We derived and applied an Acute Illness Severity score, 3, 4 
Hospital costings
The Republic of Ireland proposes to introduce a Money Follows the Patient (MFTP) system, where a case based funding model with Diagnosed Related Groups (DRG's), compares hospital costs, quality and efficiency. The calculation of costs per case is adjusted by reference to the relative cost weight of each DRG. The hospital uses a number of standard accounting costing methodologies. The predominant approaches used in this exercise were Activity Based Costing and Absorption Costing. 10, 11 The hospital costings of the price of an episode of care encompasses all costs appropriately associated with the delivery of that care. Therefore it includes: (i) Pay costs-consultants, nonconsultant hospital doctors, nursing, paramedical, administration, support services, catering, porters and maintenance, (ii) Non-pay costs-such as drugs, blood, medical and surgical supplies, radiology, laboratory equipment and supplies, heat, light and power etc. and (iii) Costs of diagnostics, medical services, theatres, laboratories, wards and overhead allocations as appropriate. This initiative gave us access, from 2008 onwards, to hospital in-patient costs by patient episode.
Results
Patient demographics
A total of 33 732 episodes were recorded in 20 305 unique patients admitted as medical emergencies over the 6-year study period. These episodes represented all emergency medical admissions, who had completed the clinical episode or who had suffered an in-hospital death, within 30 days of admission. The median (IQR) length of stay (LOS) was 5.1 (2.1, 9.8) days. The median (IQR) age was 61.6 (42.0, 77.5) years. The Charlson Comorbidity Score of 0, 1, or 2 was present in 45.3, 29.8 and 25.0%, respectively. The major disease categories (MDCs) were respiratory (25.5%), cardiovascular (16.4%), neurological (17.2%), gastrointestinal (9.9%), hepato-bilary (4.0%) and renal (5.1%). A disabling score (one point per disabling group) of zero was recorded in 9.5% of patients. The frequency of disabling scores for groups 1, 2, 3 and 4þ were 22.8, 29.0, 23.3 and 15.4%, respectively. The frequency of Sepsis Status categories 1, 2 and 3 were 76.5, 20.0 and 3.5%, respectively.
Age distribution, outcomes and risk profile
We evaluated the risk profile of each group in terms of Acute Illness Severity, Charlson Co-Morbidity Index, Chronic Disabling Disease Score and Major Disease Primary Codes in the Respiratory (MDC4), Cardiovascular (MDC5) or Neurological (MDC1). The extent of the relationship of this predictor to the age profile is remarkable. Whereas only 11.9% of episodes had the top risk Grade 6 at age <40 years, between !60 and <85 there were 56.0% in this category and !85 years the frequency was 87.5%. Charlson Co-Morbidity Index and Chronic Disabling Disease showed age-related increases, although the major alteration in frequency occurred at >60 years. Thus the frequency of the most severe category for the Charlson Index (Grade II) by the three age groups was 14.5, 34.9 and 33.4%, respectively. The most severe grade for the Disabling Disease Score (Grade 4) increased from 4.9 to 23.5 and 31.2%, respectively. Major Disease Codes in the Respiratory Cardiovascular and Neurological categories showed similar increments with small or no increases between the two upper age groups (Table 1) .
Age distribution, episode cost and risk predictors
The total hospital episode cost was determined (median cost, IQR) for age group and by risk predictor. This data were tested for an age-related trend of total episode cost and for interaction between the risk predictor and the age group ( Table 2 ). The total cost increased with age. All three age groupings were significantly different from each other in terms of costs (Scheffe's multiple comparison test: P < 0.001). Costs increased nonlinearly and beyond the 90th percentile, there was no difference in total cost related to age (<60 year median cost e14 603, !60 <85 median cost was e13 346 and !85 year median e12 988: ANOVA P ¼ 0.11).
However, it was apparent that costs were not determined by age alone, and that this association between age and increasing costs was particularly dependent upon underlying risk parameters. For example, in the case of Acute Illness Severity, the increase of risk category was the main determinant of cost, rather than the age. Below the age of 60, the median hospital episode costs increased from e1446 (95% CI: 898, 2507) with Grade 1 Severity; to e5045 (2641, 9166) at Grade 6. However, the two older groups were in fact less costly for the Grade 6 Illness Severity Category !60-e4312 (2327, 7938) and !85 e4681 (2509, 7967) respectively. Chronic Disabling Disease, like Acute Illness Severity, showed more marked increased costs between the Disabling categories rather than the age groups. Charlson Comorbidity showed incremental cost increases both within and across the age groups. Single disease MDCs showed substantial cost increments over the age categories. There were significant interactions between the risk parameters and age groups in terms of predicting total costs; generally speaking increasing age was associated with greater costs at an equivalent risk category, with the exceptions mentioned earlier.
Poisson prediction model for hospital episode costs
We modeled the total hospital episode costs, using the predictor variables of age group, Acute Illness severity, Charlson CoMorbidity Index, Chronic Disabling Disease Score and MDC Respiratory, Cardiovascular and Neurology. The initial analysis with age considered in the groups of <60, !60 and !85 showed a breakdown of 47.0, 42.4 and 10.5% of episodes with these cutoffs.
In this the IRR for the two upper groups (compared with those <60 years) were IRR 1.05 (95% CI: 1.01, 1.10) and 1.14 (95% CI: 107, 1.22). We undertook a sub-analysis with the discrete age subgroups of <40, 40-< 60, 60-< 75, 75-<85 and !85 with a frequency distribution of 22. CI: 1.42, 1.51). MDC categories for Respiratory Cardiovascular and Neurology 0.87 had lower episode costs (P < 0.001) ( Table 3 , Fig. 1a-d) .
We used the coefficients of the model to calculate a total model score for each subject and to relate that to the actual total episode costs: this increased in a predictable but nonlinear fashion (Fig 1a) . The data for Acute Illness Severity and Sepsis Status suggested that increasing levels of severity or sepsis state contributed more to the rate of increase in total hospital costs than the actual patient age (Fig 1b and c) . However, the proportion of patients over the median cost increased with age (<60 years 39.1, !60 57.8 and !85 68.9%). The AUROC of the model, to predict costs above or below the median, was 0.73 (95% CI: 0.67, 0.80) for all episodes.
We used 'margin' statistic to estimate the effect of age on total hospital costs. Margin is a statistic computed from predictions from a model while manipulating the values of the covariates. With this approach computed are levels of margins for different covariate values and the average marginal effect gives the average incremental effect of the age group on the expected total hospital cost, adjusted for the other predictors included in the model. The age group independently predicted increased total hospital costs (Fig 1d) . These significant cost predictors of age on total hospital costs disappear when the model is adjusted for hospital length of stay, implying that much of the age impact on total costs is related to the longer hospital length of stay.
Discussion
Age, considered in isolation, may be shown to be a univariate predictor of hospital episode cost. Although median costs of an acute hospital admission are higher in older people, we have established that Acute Illness Severity score, Chronic Disabling Disease score, and Sepsis Status are stronger and more reliable predictors than age alone. Given the economic burden of healthcare for society, there is pressure to use resources efficiently to improve outcomes whilst controlling costs. The world's age demographic is shifting dramatically. Although we have seen only a minor increase in the share of the world's population aged over 60 years, from 8 to 10%; this figure is expected to rise considerably to 22% over the next 40 years. This represents an increase from 800 million to 2 billion people. 12 Although we have witnessed significant advances in healthcare provision and longevity in the 20th century; this has come at a The multi-variable model estimated coefficients that were then transformed to incidence-rate ratios. The latter is a hazard rate based on the rate or incidence of counts.
cost of increased complexity and multimorbidity. In 2011, the British Geriatric Society reported that patients over 65 years constituted over 60% of hospital admissions, 65% of bed days and 70% of emergency readmissions. 13 Furthermore, they reported that people with long-term conditions were the major users of care services, making up 70% of emergency and outpatient appointments, 77% of inpatient days and 90% of the drug spend in people over 75 years. 13 A number of studies have previously shown that there is an exponential relationship between overall healthcare costs with each additional co-morbidity. [14] [15] [16] [17] Our study produced similar findings, but in the setting of an acute hospital admission. We also showed that Acute Illness Severity and Sepsis Status were important predictors of cost. Furthermore our analysis challenges the presumption that age, considered in isolation, is a useful predictor of hospital episode costs. Other health economic research points to proximity to death rather than age as the main demographic driver of healthcare costs. 18, 19 Using data from the Oxford Record Linkage Study, Seshamani and Gray 19 reported that whilst age may significantly effect quarterly costs, the incremental increase is small when compared with the tripling of costs that occurs in the final year of life.
Other health economists point to healthy ageing as an important factor in predicting future increases in health expenditure. When life expectancy increases terminal costs are postponed but the increases in health expenditure that result from longer life expectancy are not as great as one might expect from the overall increase in an older population cohort. 20 This Danish study forecasted that healthy ageing may reduce the impact of increased life expectancy on healthcare cost by 50% compared with a scenario without healthy ageing. 20 In the current economic climate there is increasing scrutiny on hospitals to curtail costs. To identify cost-savings it is first necessary to accurately model patient acuity and disease complexity; and how these might be utilized as cost predictors. This is important so as to ensure funding mechanisms accurately reflect the variation in case mix that one healthcare institution might experience when compared with another. There is increasing interest amongst health economists in developing prediction models for identifying patients at risk of becoming high-cost users of health reosurces. [21] [22] [23] [24] This in turn has been postulated as a means by which a variety of cost-reducing intervention programmes can be formulated to target so-called 'high-need, high-cost' patients. 25 Our study also has important implications for future research on cost-related studies in health economics and hospital funding. There are 'several' limitations to our study. First, it was performed in a single-centre. St James' Hospital is a tertiary referral centre, with a significant proportion of our patients diagnosed with complex medical problems. This may have influenced our findings as younger patients may therefore have presented with greater illness severity and co-morbidity. Therefore our results may not be generalizable to other healthcare institutions and need to be interpreted with caution in this regard. Our study explored the predictors of cost of an acute hospital admission; but our findings may not apply to costs in other healthcare settings such as in the primary or institutional care. Furthermore there are potential limitations associated with the risk predictors used in our study. For instance, the Acute Illness Severity score has not been externally validated in other study sites and use of Sepsis Status based on blood cultures alone as a marker of sepsis may not always accurately detect the presence of sepsis in any given patient. Nevertheless our results are from a large dataset of 33 732 hospital episodes over a 6-year period and our findings provide a useful insight into some of the potential factors that influence cost in an acute hospital admission. We expect that whilst research interest in this topic continues to grow; our data will provide useful information and direction for future health economic research.
Conclusion
We have identified that the key predictors of cost are acute illness severity, sepsis and the extent of chronic disabling disease. Although age was found to be a predictor of cost on multivariate analysis, this association was less marked and disappears when adjusted for length of stay. The shifting in the population demographic toward that of an ageing society puts pressure on health service resources and necessitates structural changes to acute medical care. In the coming decades, these demographic shifts in the developed world will continue to intensify the discrepancy between increasing health expenditure and the relative lower growth in GDP. This process threatens the fiscal sustainability of current health economic models in most advanced industrial economies. Knowledge of the reliable predictors of healthcare costs is necessary to facilitate health strategists with the tools to ensure reforms to healthcare funding accurately reflect the changing health demographic profile.
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